Investor's Business Daily on MSN
Viridian Therapeutics crashes on 'positive, but lackluster' thyroid eye disease results
Viridian Therapeutics stock crashed Monday on "positive, but lackluster" final-phase results for its thyroid eye disease ...
The data did not meet investor expectations, and could bring “fierce investor debate on commercial feasibility,” according to ...
A subcutaneous monoclonal antibody induced greater reductions in proptosis at 24 weeks than placebo for people with active ...
March 30 (Reuters) - Viridian Therapeutics said on Monday its experimental drug met the main goal in late-stage study, when tested in patients with active thyroid eye disease. The injectable drug, ...
Thyroid eye disease is a chronic condition that causes inflammation in your eyes. It affects about 25–50% of people with Graves’ disease, which is an autoimmune disorder that causes an overactive ...
Selenium supports thyroid hormone production and immune system processes. Some studies link low selenium levels with higher thyroid disease risk, including thyroid eye disease. Studies using 100 ...
Everyday Health on MSN
Thyroid eye disease and mental health: How to cope with emotional challenges
Learn smart, effective strategies for managing anxiety, depression, feelings of isolation, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results